This report focuses on the global Drug Discovery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug Discovery development in United States, Europe and China.
Drug discovery is the process by which new candidate medications are discovered.
The pharmaceutical and biotech companies are increasing their collaboration with contract development and manufacturing organizations, thus playing a crucial role in the development and innovation of new drugs. Other factors contributing to the growth of this market are – rising prevalence of a wide range of diseases (such as cardiovascular and CNS-related disorders), rising healthcare expenditure, and upcoming patent expiration of blockbuster drugs.
In 2017, the global Drug Discovery market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
The pharmaceutical and biotech companies are increasing their collaboration with contract development and manufacturing organizations, thus playing a crucial role in the development and innovation of new drugs. Other factors contributing to the growth of this market are – rising prevalence of a wide range of diseases (such as cardiovascular and CNS-related disorders), rising healthcare expenditure, and upcoming patent expiration of blockbuster drugs.
In 2017, the global Drug Discovery market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
The key players covered in this study
Pfizer
GSK
Merck
Agilent
Eli Lilly and Company
Roche
Bayer
Abbott
AstraZeneca
Shimadzu
Pfizer
GSK
Merck
Agilent
Eli Lilly and Company
Roche
Bayer
Abbott
AstraZeneca
Shimadzu
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3429237-global-drug-discovery-market-size-status-and-forecast-2018-2025
Market segment by Type, the product can be split into Small Molecule Drug
Biologics Drug
Biologics Drug
Market segment by Application, split into Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Pharmaceutical Companies
Biotechnology Companies
Market segment by Regions/Countries, this report covers United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Europe
China
Japan
Southeast Asia
India
Central & South America
Enquiry before Buying @ https://www.wiseguyreports.com/enquiry/3429237-global-drug-discovery-market-size-status-and-forecast-2018-2025
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Content:
1 Report Overview 1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Drug Discovery Market Size Growth Rate by Type (2013-2025)
1.4.2 Small Molecule Drug
1.4.3 Biologics Drug
1.5 Market by Application
1.5.1 Global Drug Discovery Market Share by Application (2013-2025)
1.5.2 Research Institutes
1.5.3 Pharmaceutical Companies
1.5.4 Biotechnology Companies
1.6 Study Objectives
1.7 Years Considered
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Drug Discovery Market Size Growth Rate by Type (2013-2025)
1.4.2 Small Molecule Drug
1.4.3 Biologics Drug
1.5 Market by Application
1.5.1 Global Drug Discovery Market Share by Application (2013-2025)
1.5.2 Research Institutes
1.5.3 Pharmaceutical Companies
1.5.4 Biotechnology Companies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends 2.1 Drug Discovery Market Size
2.2 Drug Discovery Growth Trends by Regions
2.2.1 Drug Discovery Market Size by Regions (2013-2025)
2.2.2 Drug Discovery Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
2.2 Drug Discovery Growth Trends by Regions
2.2.1 Drug Discovery Market Size by Regions (2013-2025)
2.2.2 Drug Discovery Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
……..
12 International Players Profiles
12.1 Pfizer 12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Drug Discovery Introduction
12.1.4 Pfizer Revenue in Drug Discovery Business (2013-2018)
12.1.5 Pfizer Recent Development
12.2 GSK 12.2.1 GSK Company Details
12.2.2 Company Description and Business Overview
12.2.3 Drug Discovery Introduction
12.2.4 GSK Revenue in Drug Discovery Business (2013-2018)
12.2.5 GSK Recent Development
12.3 Merck 12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Drug Discovery Introduction
12.3.4 Merck Revenue in Drug Discovery Business (2013-2018)
12.3.5 Merck Recent Development
12.4 Agilent 12.4.1 Agilent Company Details
12.4.2 Company Description and Business Overview
12.4.3 Drug Discovery Introduction
12.4.4 Agilent Revenue in Drug Discovery Business (2013-2018)
12.4.5 Agilent Recent Development
12.5 Eli Lilly and Company 12.5.1 Eli Lilly and Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Drug Discovery Introduction
12.5.4 Eli Lilly and Company Revenue in Drug Discovery Business (2013-2018)
12.5.5 Eli Lilly and Company Recent Development
12.6 Roche 12.6.1 Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Drug Discovery Introduction
12.6.4 Roche Revenue in Drug Discovery Business (2013-2018)
12.6.5 Roche Recent Development
12.7 Bayer 12.7.1 Bayer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Drug Discovery Introduction
12.7.4 Bayer Revenue in Drug Discovery Business (2013-2018)
12.7.5 Bayer Recent Development
12.8 Abbott 12.8.1 Abbott Company Details
12.8.2 Company Description and Business Overview
12.8.3 Drug Discovery Introduction
12.8.4 Abbott Revenue in Drug Discovery Business (2013-2018)
12.8.5 Abbott Recent Development
12.9 AstraZeneca 12.9.1 AstraZeneca Company Details
12.9.2 Company Description and Business Overview
12.9.3 Drug Discovery Introduction
12.9.4 AstraZeneca Revenue in Drug Discovery Business (2013-2018)
12.9.5 AstraZeneca Recent Development
12.10 Shimadzu 12.10.1 Shimadzu Company Details
12.10.2 Company Description and Business Overview
12.10.3 Drug Discovery Introduction
12.10.4 Shimadzu Revenue in Drug Discovery Business (2013-2018)
12.10.5 Shimadzu Recent Development
12.1 Pfizer 12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Drug Discovery Introduction
12.1.4 Pfizer Revenue in Drug Discovery Business (2013-2018)
12.1.5 Pfizer Recent Development
12.2 GSK 12.2.1 GSK Company Details
12.2.2 Company Description and Business Overview
12.2.3 Drug Discovery Introduction
12.2.4 GSK Revenue in Drug Discovery Business (2013-2018)
12.2.5 GSK Recent Development
12.3 Merck 12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Drug Discovery Introduction
12.3.4 Merck Revenue in Drug Discovery Business (2013-2018)
12.3.5 Merck Recent Development
12.4 Agilent 12.4.1 Agilent Company Details
12.4.2 Company Description and Business Overview
12.4.3 Drug Discovery Introduction
12.4.4 Agilent Revenue in Drug Discovery Business (2013-2018)
12.4.5 Agilent Recent Development
12.5 Eli Lilly and Company 12.5.1 Eli Lilly and Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Drug Discovery Introduction
12.5.4 Eli Lilly and Company Revenue in Drug Discovery Business (2013-2018)
12.5.5 Eli Lilly and Company Recent Development
12.6 Roche 12.6.1 Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Drug Discovery Introduction
12.6.4 Roche Revenue in Drug Discovery Business (2013-2018)
12.6.5 Roche Recent Development
12.7 Bayer 12.7.1 Bayer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Drug Discovery Introduction
12.7.4 Bayer Revenue in Drug Discovery Business (2013-2018)
12.7.5 Bayer Recent Development
12.8 Abbott 12.8.1 Abbott Company Details
12.8.2 Company Description and Business Overview
12.8.3 Drug Discovery Introduction
12.8.4 Abbott Revenue in Drug Discovery Business (2013-2018)
12.8.5 Abbott Recent Development
12.9 AstraZeneca 12.9.1 AstraZeneca Company Details
12.9.2 Company Description and Business Overview
12.9.3 Drug Discovery Introduction
12.9.4 AstraZeneca Revenue in Drug Discovery Business (2013-2018)
12.9.5 AstraZeneca Recent Development
12.10 Shimadzu 12.10.1 Shimadzu Company Details
12.10.2 Company Description and Business Overview
12.10.3 Drug Discovery Introduction
12.10.4 Shimadzu Revenue in Drug Discovery Business (2013-2018)
12.10.5 Shimadzu Recent Development
Continued…..
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
No comments:
Post a Comment